Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 生物資源暨農學院
  3. 農業化學系
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/35166
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor李敏雄(Ming-Hsiung Lee)
dc.contributor.authorYin-An Chenen
dc.contributor.author陳盈安zh_TW
dc.date.accessioned2021-06-13T06:42:48Z-
dc.date.available2007-08-04
dc.date.copyright2005-08-04
dc.date.issued2005
dc.date.submitted2005-07-30
dc.identifier.citation林芊。2004。由Serratia marcescens 生產prodigiosin 之研究。國立台灣大學農業化學研究所論文。
姚惠芳。2000。由Serratia marcescens FC-R1 生產紅色色素之研究。國立台灣大學農業化學研究所論文。
蘇遠志與黄世佑。1996。微生物化學工程學。華香園出版社,台北。
Alberti. L., and R. M. Hashey. 1990. Differentiation of Serratia marcescens 274 into swimmer and swamer cells. J. Bacteriol., 172: 4322-4328.
Bennett J.W., Bentley R. 2000. Seeing red: the story of prodigiosin. Adv. Appl. Microbiol. 47: 1-32.
Button, G. L., M. A. Miller, and J. C. Tsang. 1975. Antibiogram and lipid analysis of a pigmented strain of Serratia marcescens and its nonpigmented variants. Antimicrob. Agents Chemother., 7: 219-222.
Campàs, C., M. Dalmau, B. montaner, M. Barragán, B. Bellosillo, D. Colomer, G. Pons, R. Pérez-Tomás and J. Gil. 2003. Prodigiosin induces apoptosis of B and T cells from B-cell chronic lymphocytic leukemia. Leukemia, 17: 746-750.
Castro, A. J. 1967. Antimalarial activity of prodigiosin. Nature (London), 213: 903-904.
Clements-Jewery, S. 1976. The reversal of glucose repressed prodigiosin production in Serratia marcescens by the cyclic 3’5’-adenosine monophosphate inhibitor theophylline. Experientia, 32: 421-533.
Datta, A. R. and M. H. kothary. 1993. Effects of glucose, growth temperature, and pH on literiolysin O productuin in Listeria monocytogenes. Appl. Environ. Microbiol., 59: 3495-3497.
Díaz-Ruis, C., B. montaner, and R. Pérez-Tomás. 2001. Prodigiosin induces cell death and morphological changes indicative of apoptosis in gastric cancer cell line HGT-1. Histol. Histopathol., 16: 415-421.
Ding. M. J. and R. P. Williams. 1983. Biosynthesis of prodigiosin by white strains of Serratia marcescens isolated from patients. J. Clin. Microbiol., 17: 476-480.
Eaves, G. N., and C. D. Jefferies. 1963. Isolation and properties of an exocellular nuclease of Serratia marcescens. J. Bacteriol., 85: 273-278.
Ehrlich, R. 1954. Induced filament formation and color changess in a strain of Serratis marcescens. J. Bacteriol., 68: 752-753.
Fuller, A. T. and J. M. Horton. 1950. Marcescun, and antibiotic substance from Serratia marcescens. J. Gen Microbiol., 4: 417-433.
Füller, A. 2003. Chemistry and biology of reseophilin and the prodigiosin alkaloids: a survery of the last 2500 years. Angew. Chem. Int. Ed., 42: 3582-3603.
Gerber. N. N. 1975. Prodigiosin-like pigments. Crit. Rev. Microbiol., 3 : 469-485.
Grimont, P. A. D., and F. Grimont. 1978. The genus Serratia. Annu. Rev. Microbiol., 32 : 221-248.
Grimont, P. A. D., and F. Grimont. 1984. Bergey’s Manual of Systematic Bacteriology (N. R. Krieg. Ed.). Willams & wilkins, Baltimore, USA., 1: 477-484.
Han, S. B., H. M. Kim, Y. H. Kim, C. W. Lee, E. Jang, and K. H. Son. 1998. T-cell specific immunosuppression by prodigiosin isolated from Serratia marcescens. Int. J. Immunopharmacol., 20: 1-13.
Harrison, F. C. 1924. The miraculous micro-organism. Trans. Roy. Soc., Sec V. Ser. III., 18: 1-17.
Heinemann, B., A. J. Howard, and H. J. Palocz. 1970. Influence of dissolved oxygen levels on production of L-asparaginase and prodigiosin by Serratia marcescens. Appl. Microbiol., 19: 800-804.
Itami, C., H. Matsunana, T. Sawada, H. Sakurai, and Y. Kimura. 1993.
Superoxide Dismutase Mimetic Activities of Metal Complexes of L-2(2-Pyridyl)-1-pyrroline-5-carboxylic Acid (Pyrimine). Biochem. Biophys. Res. Commun., 197: 536-541
Kalesperis, G. S., K. V. Prahlad, and D. L. Lynch. 1975. Toxigenic studies with the antiniotic pigments from Serratia marcescens. Can. J. Microbiol., 21: 213-220.
Kataoka, T., M. Moroi, S. Ohkuma, T. Waritani, J. Magae, A. Takatsuki, S. Kondo, M. Yamasaki, and K. Nagai. 1995b. Prodigiosin 25-C uncouples vacuolar type H+-ATPase, inhibits vacuolar acidification and affects glycoprotein processing. FEBS Lett., 359: 53-59.
Kamate, K., S. Okamoto, Si Oka, H. Kamate, H.Y. Agisawa, and H. Hirata. 2000. Cycloprodigiosin hydrochloride suppresses tumor necrosis factor (TNF) –induced transcriptional activation by NF-κB. FEBS Lett., 507: 74-80.
Kawauchi, K., K. Shibutani, H.Y. Agisawa, H. Kamate, S. Nakatsuji, and H. Anzai. 1997. A possible immunosuppressant, cycloprodigiosin hydrochloride, obtained from Pseudoalteromonas denitrificans. Biochem. Biophys. Res. Commun., 237: 543-547.
Konno, H., H. Matsuya, M. Okamoto, T. Sato, Y. Tanaka, K. Yokoyama, T. Kataoka, K. Nagai, H. H. Wasserman, and S. Ohkuma. 1998.
Prodigiosins uncouple mitochondrial and bacterial F-ATPases:
evidence for their H+/Cl- symport activity. J. Biochem., 124: 547-556.
Lack, A. 1949. Prodigiosin. I. Antibiotic action on Coccidioides immitis in vitro. Proc. Soc. Exp. Bio. Med., 72: 656-658.
Magae, J., M. W. Miller, K. Nagai, and G. M. Shearer. 1996. Effect of metacycloprodigiosin, an inhibitor of killer T cells on murine skin and heart transplants. J. Antibiot., 49: 86-90.
Merlino C. P. 1924. Bartolomeo Bizio’s letter to the most eminent priest, Angelo Bellani, concerning the phenomenon of the red-colored polenta. J. Bacteriol., 9: 527-543.
Miesenheimer, T. J., R. F. Anderson, A. A. Lagoda, and D. D. Tyler. 1965. Production of 2-ketogluconic acid by Serratia marcescens. Appl. Microbiol., 13: 393-396.
Montaner, B. S. Navarro, M. PiquéM. Vilaseca, M. Martinell, E. Giralt, J.Gil, and R. Pérez-Tomás. 2000. Prodigiosin from the supernatant of Serratia marcescens induces apoptosis in haenatopoietic cancer cell line. Br. J. Pharmacol., 131: 585-593.
Morrison, D. A. 1966. Prodigiosin systhesis in mutants of Serratia marcescens. J. Bacteriol., 91: 1599-1604.
Mortellaro, A., S. Songia, P. Gnocchi, M. Gerrari, C. Fornasiero, and R D’Slessio. 1999. New immunosuppressive drug PNU156804 blocks IL-2 dependent proliferation and NF-κB and AP-1 activation. J. Immunol., 162: 7102-7109.
Ohkuma, S., T. Sato, M. Okamoto, H. Matsuya, K. Arai, T. Kataoka, K., Nagai, and H. H. Wasserman. 1998. Prodigiosins uncouple lysosomal vacuolar- type ATPase through promotation of H+/Cl- symport.
Biochem. J., 334: 731-741.
O’Rear, J., L. Alberti, and R. M. Harshey. 1992. Mutations that impair swarming motility in Serratia marcescens 274 include but not limited to those affecting chemotaxis or flagellar function. J. Bacteriol., 174: 6125-6137.
Padman, J. 1996. Major metalloprotease gene of Serratia marcescens is conserved and provides a molecular typing method to differentiate clinical isolated. J. Microbiol. Methods., 26: 261-269.
Paruchuri, D. K., and R. M. Harshey. 1987. Glagellar changes in Serratia marcescens in associated with color changes. J. Bacteriol., 169: 61-65.
Prinsloo, H. E. 1966. Bacteriocins and phages produced by Serratia marcescens. J. Gen. Microbiol., 45: 202-212.
Qadri, S. M. H., and R. P. Willaims. 1972. Induction of prodigiosin biosynthesis after shift-down in temperature of nonproliferating cells of Serratia marcescens, Appl. Microbiol., 23: 704-709.
Reed, G. B. 1937. Independent changes of several characteristics in S. marcescens. J. Bacteriol., 34: 255-265.
Regassa, B. L., R. P. Novick, and M. J. Betley. 1992. Glucose and nonmantained pH decrease ecpression of the accessory gene regulator (agr) in Staphylococcus aureus. Infect. Immum., 60: 3381-3388.
Reid, J. D., and D. M. Ogrydziak. 1981. Chitinase-overproducing mutant of Serratia marcescens. Appl. Environ. Microbiol., 41: 664-669.
Ricardo, P. T., M. Beatriz, L. Esther,and S. C. Vanessa. 2003. The prodigiosin, proapoptotic drugs with anticancer properties. Biochem. Pharmacol. 66: 1447-1452.
Salamone, P. R., and R. J. Wodzinski. 1997. Production, Purification and characterization of a 50-kDa extracellular metalloprotease from Serratia marcescens. Appl. Microbiol. Biotech., 48: 317-324.
Sato, T., H. Konno, Y. Tanaka, T. Kataoka, K. Nagai, H. H. Wasserman, and S. Ohkuma. 1998. Prodigiosin as a new group of H+/Clsymporters that uncouple proton translocators. J. Biol. Chem., 273:
21455-21462.
Shiman, R., and J. B. Neilands. 1965. Isolation, characterization, and synthesis of pyrimine, and iron(II)-binding agent from Pseudomonas.
GH. Biochem., 4: 2266-2236
Silverman, M. P., and E. F. Munoz. 1973. Effect of iron and salt on prodigiosin synthesis in Serratia marcescens. J. Bacteriol., 114: 999-1006.
Solé, M., N. Rius, A. Francia, and J. G. Lorén. 1994. The effect of pH on prodigiosin production by non-proliferation cells os Serratia marcescens. Lett. Appl. Microbiol., 19: 341-344.
Solé, M., A. Francia, N. Rius, and J. G. Lorén. 1997. The role of pH in the ‘glucose effect’ on prodigiosin production by non-proliferating cells of Serratia marcescens. Lett. Appl. Microbiol., 25: 81-84.
Solé, M., N. Rius, and J. G. Lorén. 2000. Rapid ectracellular acidification induced by glucose metabolism in non-proliferating cells of Serratia marcescens. Internatl. Microbiol., 3: 39-43.
Songia, S., A. Mortellaro, S. Taverna, C. Fornasiero, E. A. Scheiber, and E. erba. 1997. Characterization of the new immunosuppressive drug undecylprodigiosin in human lymphocytes. J. Immunol., 158:
3987-3995.
Stepkowski, S. M., R. A. Erwin-Cohen, F. Behbod, M. Wang, X. Qu, and N. Tejpal. 2002 Selective inhibitor or Janus tyrosine kinase 3, PNU156804, prolongs allograft survival and acts synthesistically with cyclosporine but additively with rapamycin. Blood, 99: 680-689.
Willaims, R. P. 1973. Biosynthesis of prodigiosin, a secondary metabolite of Serratia marcescens. Appl. Microbiol., 25: 396-402.
Williams, R. P., and C. L. Gott. 1964. Inhibiton by streptomycin of the biosynthesis of prodigiosin. Biochem. Biophys. Res. Commun., 16: 47-52.
Williams, R. P., C. L. Gott, S. M. H. Qadri, and R. H. Scott. 1971a.
Influence of temperature of incubation and type of growth medium on pigmentation in Serratia marcescens. J. Bacteriol., 106: 438-443.
Willaims, R. P., C. L. Gott, and S. M. H. Qadri. 1971b. Incubation of pigmentation in nonproliferating cells of Serratia marcescens by addition of single amino acids. J. Bacteriol., 106: 444-448.
Williams, R. P., J. A. Green, and D. A. Rappoport. 1956. studies on pigmentation of Serratia marcescens. I. Spectral and paper chromatographic properties of prodigiosin. J. Bacteriol., 71: 115-120.
Willaims, R. P., R. H. Scott, D. V. Lim, and S. M. H. Qadri. 1976. Macromolecular synthesis during biosynthesis of prodigiosin by Serratia marcescens. Appl. Environ. Microbiol., 31: 70-77.
Williams, R. P., W. W. Taylor, D. Hawkins, and I. L. Roth. 1958. A water-soluble, diffusible pigment produced by a strain of Serratia marcescens (Chromobacterium prodigiosum). Nature (London), 182: 1028-1029.
Williamson N. R., H. T. Simonsen, R. A. A. Ahmed, G. Goldet, H. Slater, L. Woodley, F. J. Leeper, and G. P. C. Salmond. 2005. Biosynthesis of the red antibiotic, prodigiosin, in Serratia : identification of a novel 2-methyl-3-n-amylpyrrole (MAP) assembly pathway, definition of the terminal condensing enzyme, and implications for undecylprodigiosin biosynthesis in Streptomyces. Molecular Microbiology, 56: 971–989.
Yamamoto, D., Y. Kiyozuca, Y. Uemura, C. Yamamoto, H. Takemoto, and H. Hirata. 2000. Cycloprodigiosin hydrochloride, a H+/Cl- Symporter, induces apoptosis in human breast cancer cell line. J. Cancer Res. Clin. Oncol., 126: 191-197.
Yamamoto, C., H. Takemoto, K. Kuno, D. Yamamoto, A. Tsubura, and K. Kamata. 1999. Cycloprodigiosin hydrochloride, a new H+/Cl- Symporter, induces a poptosis in juman and rat hepatocellular cancer cell lines in vistro and inhibits the growth of hepatocellular carcinoma xengrafts in nude mice. Hepatology., 30: 894-902.
Yasutaka, M., K. Kenji, H. Quamrul, S. Toshifumi, M. Tuji, Y. Kenji, and T. Eiichi. 1997. Purfication and characterization of a cold-active protease from psychrotrophic Serratia marcescens AP3081. J.A.O.C.S., 74:1377-1383.
Yu,V. L., 1979. Serratia marcescens. Historical perspective and clinical review. N. Eng. J. Med., 300: 887-893.
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/35166-
dc.description.abstract中文摘要
Prodigiosin 中文名稱為靈菌紅素,具linear tripyrrole結構,為Serratia marcesens、Vibrio psychroerythrus、Pseudomonas magnesiorubra、Streptomyces spp. 等微生物的二次代謝物。此一色素及其類似物除具有抗生素、免疫抑制劑的生理功效,近年來研究指出prodigiosin及其類似物都具有抗癌的功效。本篇研究以天然基質為基礎,以Serratia marcescens BCRC 11576為生產菌株,再添加了0.5 % 碳酸鈣之後,有效避免培養過程中pH下降的問題。最終培養基定為1.4 % 大豆粉、0.5 % CaO3、0.6 % Fructose、0.1 % KCl、0.05 % MgSO4•7H2O、0.2 % 小麥粉,在27 ℃ 120 rpm下培養兩天後可得81.99 mg prodigiosin / 100 mL broth,培養三天可得96.86 mg prodigiosin / 100 mL broth 的高產量,提供了生產prodigiosin相當經濟的培養條件。
zh_TW
dc.description.abstractAbstract
The structure of prodigiosin is a linar tripyrrole which is a typical secondary metabolite produced by Serratia marcesens, Vibrio psychroerythrus, Pseudomonas magnesiorubra, and Streptomyces spp. The characteristics of prodigiosin families were reported characteristics of having not only having antibiotics and immunosuppressant activities, but also given anticancer activity recently. In this study, the strain, Serratia marcescens BCRC 11576, was used which cultured on a natural medium to produce prodigiosin. In addition, in order to effective to prevent pH in the period of cultivation decrease the culture was added with 0.5 % CaCO3. Finally, a complete natural medium was composed of 1.4 % soybean flour, 0.5 % CaCO3, 0.6% fructose, 0.1 % KCl, 0.05 % MgSO4•7H2O,and 0.2 % wheat flour was established. This medium induced formation of 81.99 mg prodigiosin per 100 mL broth after incubation for two days, and 96.86 mg prodigiosin per 100mL broth for three days under 27 ℃, 120 rpm. Therefore, it seemed so economic a way to produce prodigiosin with this medium.
en
dc.description.provenanceMade available in DSpace on 2021-06-13T06:42:48Z (GMT). No. of bitstreams: 1
ntu-94-R92623024-1.pdf: 756020 bytes, checksum: 03a4469f62a8061bb603ea17cd966709 (MD5)
Previous issue date: 2005
en
dc.description.tableofcontents目 次
目 次 I
圖 次 III
表 次 V
中文摘要 VI
英文摘要 VII
壹、前言 1
貳、文獻整理
一、Serratia marcescens之源起、分布、特性、型態及其應用 2
二、Prodigiosin之源起、生合成及其應用 8
三、生產pordigiosin之相關研究 14
參、材料與方法
一、實驗架構 16
二、儀器設備 17
三、材料 18
四、實驗方法 21
肆、結果與討論
一、 Serratia marcescens BCRC 11576在幾個常見培養基上生長情形 30
二、Prodigiosin 生長條件之探討 32
三、其他影響因子之探討 50
四、Prodigiosin之純化 54
五、葡萄糖造成培養液pH值下降成因之探討 57
伍、結論 62
陸、參考文獻 64
dc.language.isozh-TW
dc.subject靈菌紅素zh_TW
dc.subject黏質沙雷氏桿菌zh_TW
dc.subjectSerratia marcescensen
dc.subjectprodigiosinen
dc.title以Serratia marcescens BCRC 11576 生產prodigiosin之研究zh_TW
dc.titleStudies on the production of prodigiosin by Serratia marcescens BCRC 11576en
dc.typeThesis
dc.date.schoolyear93-2
dc.description.degree碩士
dc.contributor.oralexamcommittee蘇南維(Nan-Wei Su),林子清(Tze-Ching Lin),古國隆(Kuo-Lung Ku),王苑春(Yuan-Chuen Wang)
dc.subject.keyword黏質沙雷氏桿菌,靈菌紅素,zh_TW
dc.subject.keywordSerratia marcescens,prodigiosin,en
dc.relation.page72
dc.rights.note有償授權
dc.date.accepted2005-07-31
dc.contributor.author-college生物資源暨農學院zh_TW
dc.contributor.author-dept農業化學研究所zh_TW
顯示於系所單位:農業化學系

文件中的檔案:
檔案 大小格式 
ntu-94-1.pdf
  未授權公開取用
738.3 kBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved